1. Home
  2. Publications
  3. Publications in 2021

Publications in 2021

"Falkirk Wheel" by Chris Hoare is licensed under CC BY-NC 2.0
Enter any text in the title of the paper (e.g. 'Breast'; 'Scotland')
The full UKIACR member associated with this publication

  1. The Impact of the COVID-19 Pandemic on Endometrial Cancer and Endometrial Hyperplasia Diagnosis: A Population-Based Study

    Wylie, J., Quinn, D., Donnelly, D., McCluggage, W. G., Coleman, H., Gavin, A. & McMenamin, Ú
    American Journal of Obstetrics and Gynecology, Dec 2021 https://doi.org/10.1016/j.ajog.2021.12.259

  2. Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey

    ENCR Steering Committee
    European Journal of Public Health, Dec 2021 https://doi.org/10.1093/eurpub/ckab214

  3. Stability of health-related quality of life and morbidity burden from 18 months after diagnosis of prostate cancer: results of a UK-wide population-based outcome cohort

    Mason, S. J., Downing, A., Wilding, S., Hounsome, L., Wright, P., Watson, E., Wagland, R., Butcher, H., Kind, P., Selby, P., Gavin, A. & Glaser, A. W.,
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Dec 2021 https://doi.org/10.1007/s00520-021-06650-7

  4. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

    Milena Falcaro, Alejandra Castañon, Busani Ndlela, Marta Checchi, Kate Soldan, Jamie Lopez-Bernal, Lucy Elliss-Brookes, Prof Peter Sasieni
    The Lancet, December 2021 https://doi.org/10.1016/S0140-6736(21)02178-4

  5. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers

    Dyba, T., Randi, G., Bray, F., Martos, C., Giusti, F., Nicholson, N., Gavin, A., Flego, M., Neamtiu, L., Dimitrova, N., Negrão Carvalho, R., Ferlay, J. & Bettio
    European Journal of Cancer. 157, p. 308-347 Nov 2021 https://doi.org/10.1016/j.ejca.2021.07.039

  6. Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England

    Anya Burton, Vinay K. Balachandrakumar, Robert J. Driver, Daniela Tataru, Lizz Paley, Aileen Marshall, Graeme Alexander, Ian A. Rowe, HCC-UK/BASL/NCRAS Partnership, Daniel H. Palmer & Tim J. S. Cross
    British Journal of Cancer, November 2021 https://doi.org/10.1038/s41416-021-01509-4

  7. International variation in oesophageal and gastric cancer survival 2012–2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)

    Melina Arnold, Eileen Morgan, Aude Bardot, Mark J Rutherford, Jacques Ferlay, Alana Little, Bjorn Møller, Oliver Bucher, Prithwish De, Ryan R Woods, Nathalie Saint- Jacques, Anna T Gavin, Gerda Engholm, Michael P Achiam, Geoff Porter, Paul M Walsh, Sally Vernon, Serena Kozie, Agnihotram V Ramanakumar, Charlotte Lynch, Samantha Harrison, Neil Merrett, Dianne L O’Connell, Tom Mala, Mark Elwood, John Zalcberg, Dyfed W Huws, David Ransom, Freddie Bray, Isabelle Soerjomataram
    BMJ Journals Gut, Nov 2021 http://dx.doi.org/10.1136/gutjnl-2021-325266

  8. Cancer detection via primary care urgent referral and association with practice characteristics: a retrospective cross-sectional study in England from 2009/2010 to 2018/2019

    Thomas Round, Mark Ashworth, Veline L’Esperance, Henrik Møller
    British Journal of General Practice https://doi.org/10.3399/BJGP.2020.1030

  9. Inpatient admissions and outpatient appointments in the first year post cancer diagnosis: A population based study from England

    Joanna Pethick, Cong Chen, James Charnock, Rachel Bowden, Evangelia Tzala
    Cancer Epidemiology https://doi.org/10.1016/j.canep.2021.102003

  10. Routes to diagnosis and the association with the prognosis in patients with cancer – A nationwide register based cohort study in Denmark

    Bolette Danckert, Alina Zalounina Falborg, Niels Lyhne Christensen, Henrik Frederiksen, Georgios Lyratzopoulos, Sean McPhail, Jesper Ryg, Peter Vedsted, Linda Aagaard Thomsen, Henry Jensen
    Cancer epidemiology https://doi.org/10.1016/j.canep.2021.101983

  11. A summary of the updated report on the incidence and epidemiological trends of keratinocyte cancers in the United Kingdom 2013-2018

    M.M. Kwiatkowska, S. Ahmed, M.R. Ardern-Jones, L.A. Bhatti, T.O. Bleiker, A. Gavin, S. Hussain, D.W. Huws, L. Irvine, S.M. Langan, G.W.M. Millington, H. Mitchell, R. Murphy, L. Paley, C.M. Proby, C. Thomson, R. Thomas, C. Turner, S. Vernon, Z.C. Venables
    British Journal of Dermatology https://doi.org/10.1111/bjd.20764

  12. Comparison of liver cancer incidence and survival by subtypes across seven high-income countries

    Rutherford, M. J., Arnold, M., Bardot, A., Ferlay, J., De, P., Tervonen, H., Little, A., Bucher, O., St Jacques, N., Gavin, A., Engholm, G., Møller, B., O'Connell, D. L., Merrett, N., Parkin, D. M., Bray, F. & Soerjomataram, I.
    International Journal of Cancer https://doi.org/10.1002/ijc.33767

  13. An updated report on the incidence and epidemiological trends of keratinocyte cancers in the United Kingdom 2013–2018

    M. Kwiatkowska, S. Ahmed, M. Ardern-Jones, L. A. Bhatti, T. O. Bleiker, A. Gavin, S. Hussain, D. W. Huws, L. Irvine, S. M. Langan, G. W. M. Millington, H. Mitchell, R. Murphy, L. Paley, C. M. Proby, C. S. Thomson, R. Thomas, C. Turner, Z. C. Venables
    Skin Health and Disease (OpenAccess) https://doi.org/10.1002/ski2.61

  14. International variation in childhood cancer mortality rates from 2001-2015: comparison of trends in the International Cancer Benchmarking Partnership countries

    Lesley Smith, Charles A Stiller, Joanne F Aitken, Lisa L Hjalgrim, Tom Johannesen, Paivi Lahteenmaki, Martin G McCabe, Robert Phillips, Kathy Pritchard-Jones, Eva Steliarova-Foucher, Jeanette F Winther, Ryan R Woods, Adam W Glaser, Richard G Feltbower
    International Journal of Cancer https://doi.org/10.1002/ijc.33774

  15. Abdominal cancer symptoms: Evaluation of the impact of a regional public awareness campaign

    Nicola Torrance, Chloe J. Bright, Helen L. Hill, Jennie Fergusson, Catriona Kennedy, Vivian Mak, Carolynn Gildea, Andy Nordin,
    European journal of Cancer Care https://doi.org/10.1111/ecc.13500

  16. CanStaging+: an electronic staging tool for population-based cancer registries

    Isabelle Soerjomataram, Morten Ervik, Colin Fox, Sinead Hawkins, Kenneth Yeung, Giulio Napolitano, Zuzanna Tittenbrun, Freddie Bray, Anna Gavin
    2021 Aug;22(8):1069 PMID: 34339643

  17. International perspectives on suboptimal patient‐reported outcome trial design and reporting in cancer clinical trials: A qualitative study

    Ameeta Retzer, Melanie Calvert, Khaled Ahmed, Thomas Keeley, Jo Armes, Julia M Brown, Lynn Calman, Anna Gavin, Adam W Glaser, Diana M Greenfield, Anne Lanceley, Rachel M Taylor, Galina Velikova, Michael Brundage, Fabio Efficace, Rebecca Mercieca-Bebber, Madeleine T King, Derek Kyte
    Aug;10(16):5475-5487 PMID: 34219395

  18. International differences in lung cancer survival by sex, histological type and stage at diagnosis; an ICBP SURVMARK-2 Study

    ICBP SURVMARK-2 Local Leads
    Thorax https://doi.org/10.1136/thoraxjnl-2020-216555

  19. Oral etoposide as a single agent in childhood and young adult cancer in England: Still a poorly evaluated palliative treatment

    Jess Fraser, Fahmina Fardus-Reid, Lucy Irvine, Lucy Elliss-Brookes, Lorna Fern, Alison L. Cameron, Kathy Pritchard-Jones, Richard G. Feltbower, Jon Shelton, Charles Stiller, Martin G. McCabe
    Pediatric blood and Cancer https://doi.org/10.1002/pbc.29204

  20. COVID-19 in children with haematological malignancies

    Gerard Cathal Millen, Roland Arnold, Jean-Baptiste Cazier, Helen Curley, Richard Feltbower, Ashley Gamble, Adam Glaser, Richard G Grundy, Laura Kirton, Lennard Y W Lee, Martin G McCabe, Claire Palles, Bob Phillips, Charles A Stiller, Csilla Varnai, Pamela Kearns
    BMJ Journals http://dx.doi.org/10.1136/archdischild-2021-322062

  21. Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study

    Ashleigh C Hamilton, David W Donnelly, Maurice B Loughrey, Richard C Turkington, Colin Fox, Deirdre Fitzpatrick, Ciaran E O'Neill, Anna T Gavin, Helen G Coleman
    2021 Jul 1;1-8 PMID: 34211120

  22. Data Resource Profile: The Virtual Cardio-Oncology Research Initiative (VICORI) linking national English cancer registration and cardiovascular audits

    Michael J Sweeting, Clare Oliver-Williams, Lucy Teece, Catherine A Welch, Mark A de Belder, Briana Coles, Paul C Lambert, Lizz Paley, Mark J Rutherford, Lucy Elliss- Brookes, John Deanfield, Mick D Peake, David Adlam on behalf of the VICORI Collaborative
    International Journal of Epidemiology https://doi.org/10.1093/ije/dyab082

  23. Case-ascertainment of acute myocardial infarction hospitalisations in cancer patients: a cohort study using English linked electronic health data

    Coles B, Teece L, Weston C, de Belder MA, Oliver-Williams C, Welch CA, Rutherford MJ, Lambert PC, Bidulka P, Paley L, Nitsch D, Deanfield J, Peake MD, Adlam D, Sweeting MJ, VICORI collaborative
    European Heart journal https://doi.org/10.1093/ehjqcco/qcab045

  24. Describing socio-economic variation in life expectancy according to an individual's education, occupation and wage in England and Wales: An analysis of the ONS Longitudinal Study

    Fiona C. Ingleby, Laura M. Woods, Iain M. Atherton, Matthew Baker, Lucy Elliss-Brookes, Aurélien Belot
    SSM - Population Health https://doi.org/10.1016/j.ssmph.2021.100815

  25. Community prescribing for cancer patients at the end of life: a national study

    Gabrielle Emanuel, Julia Verne, Karen Forbes, Luke Hounsome , Katherine E Henson
    BMJ Supportive & Palliative Care http://dx.doi.org/10.1136/bmjspcare-2021-002952

  26. A registry study of relapsed or refractory multiple myeloma pre-exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38-targeted monoclonal antibody therapy in England

    Ahmed Elsada, Amy Zalin-Miller, Craig Knott, Leonidas Caravotas
    eJHaem https://doi.org/10.1002/jha2.214

  27. Using the Framework Method for the Analysis of Qualitative Dyadic Data in Health Research

    Collaço, N., Wagland, R., Alexis, O., Gavin, A., Glaser, A. & Watson, E. K
    Qualitative Health Research https://doi.org/10.1177/10497323211011599

  28. The impact of the COVID-19 pandemic on skin cancer incidence and treatment in England, 2020

    Z. C. Venables, S. Ahmed, T. O. Bleiker, J. Broggio, M. Kwiatkowska, N. J. Levell, G. W. M. Millington, L. Paley, E. Payne, C. M. Proby, S. Vernon, S. McPhail
    British Journal of Dermatology https://doi.org/10.1111/bjd.20409

  29. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes

    James W F Catto, Amy Downing , Samantha Mason, Penny Wright, Kate Absolom, Sarah Bottomley, Luke Hounsome, Syed Hussain, Mohini Varughese, Caroline Raw , Phil Kelly, Adam W Glaser
    European Urology https://doi.org/10.1016/j.eururo.2021.01.032

  30. Primary liver cancer in the UK: Incidence, incidence based mortality, and survival by subtype, sex, and nation

    Anya Burton, Daniela Tataru, Robert J. Driver, Thomas G. Bird, Dyfed Huws, David Wallace, Timothy J.S. Cross, Ian A. Rowe, Graeme Alexander, Aileen Marshall, on behalf of the HCCUK/ BASL/NCRAS Partnership Steering Group
    JHEP reports https://doi.org/10.1016/j.jhepr.2021.100232

  31. Stage–specific incidence trends of renal cancers in the East of England, 1999–2016

    Annie Herbert, Matthew E. Barclay, Minjoung M. Koo, Brian Rous, David C. Greenberg, Gary Abel, Georgios Lyratzopoulos
    Cancer epidemiology http://dx.doi.org/10.1016/j.canep.2020.101883

  32. Systematic review of the use of translated patient-reported outcome measures in cancer trials

    A. L. Slade, A. Retzer, K. Ahmed, D. Kyte, T. Keeley, J. Armes, J. M. Brown, L. Calman, A. Gavin, A. W. Glaser, D. M. Greenfield, A. Lanceley, R. M. Taylor, G. Velikova, G. Turner and M. J. Calvert
    2021 Apr 26;22(1):306. PMID: 33902699

  33. Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation

    Anya Burton, Daniela Tataru, Robert J. Driver, Thomas G. Bird, Dyfed Huws, David Wallace, Timothy J.S. Cross, Ian A. Rowe, Graeme Alexander, Aileen Marshall, on behalf of the HCC-UK/BASL/NCRAS Partnership Steering Group
    2021 Jan 19;3(2):100232 PMID: 33748727

  34. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study

    Prof Eva J A Morris, Raphael Goldacre, Enti Spata, Marion Mafham, Prof Paul J Finan, Jon Shelton, Prof Mike Richards, Katie Spencer, Prof Jonathan Emberson, Sam Hollings, Paula Curnow, Dominic Gair, Prof David Sebag-Montefiore, Prof Chris Cunningham, Prof Matthew D Rutter, Brian D Nicholson, Jem Rashbass, Prof Martin Landray, Prof Rory Collins, Prof Barbara Casadei, Prof Colin Baigent
    The Lancet Gastroenterology & Hepatology https://doi.org/10.1016/S2468-1253(21)00005-4

  35. P78.01 Nivolumab in Second Line Non-Small Cell Lung Cancer – Comparing Real-World Outcomes in England to CheckMate (CM) 017 and 057

    S Popat, N. Tanna, S. Hartridge- Lambert, C. Kiff, A. Sowdani, B. Rothwell, T. Henrik-Brodtkorb, C. Ling, R. Smittenaar, M. Bomb, A. Turnbull, S. Lawton
    Journal of Thoracic Oncology http://dx.doi.org/10.1016/j.jtho.2021.01.1164

  36. Socio-demographic variation in stage at diagnosis of breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, renal and ovarian cancer in England and its population impact

    M. E. Barclay, G. A. Abel, David. C. Greenberg, B. Rous, G. Lyratzopoulos
    British Journal of Cancer http://dx.doi.org/10.1038/s41416-021-01279-z

  37. Experiences of Support for Sexual Dysfunction in Men With Prostate Cancer: Findings From a U.K.-Wide Mixed Methods Study

    Eila Watson, Sarah Wilding, Lauren Matheson, Jo Brett, Eilis McCaughan, Amy Downing, Penny Wright, William Cross, Peter Selby, Hugh Butcher, Adam Glaser, Anna Gavin, Richard Wagland
    2021 Feb 25;S1743-6095(21)00001-1 PMID: 33642238

  38. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study

    Salvatore Vaccarella, Joannie Lortet-Tieulent, Murielle Colombet, Louise Davies, Charles A Stiller, Joachim Schüz, Kayo Togawa, Freddie Bray, Silvia Franceschi, Luigino Dal Maso, Eva Steliarova-Foucher, on behalf of the IICC-3 contributors
    The Lancet Diabetes & Endocrinology https://doi.org/10.1016/S2213-8587(20)30401-0

  39. The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study

    Katie Spencer, Christopher M Jones, Rebecca Girdler, Catherine Roe, Michael Sharpe, Sarah Lawton, Louise Miller, Philippa Lewis, Mererid Evans, Prof David Sebag- Montefiore, Tom Roques, Rebecca Smittenaar, Prof Eva Morris
    The Lancet Oncology https://doi.org/10.1016/S1470-2045(20)30743-9

  40. Treatable but not curable cancer in England: a retrospective cohort study using cancer registry data and linked data sets

    Rachel White, Fintan Stanley, Jen Than, Archie Macnair, Joanna Pethick, Gregory Fallica, Luke Hounsome, Jane Maher
    BMJ Journals http://dx.doi.org/10.1136/bmjopen-2020-040808

  41. Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet)

    Charles A Stiller, Laura Botta, Maria José Sánchez Perez, María Dolores Chirlaque López, Rafael Marcos-Gragera, Tiziana Scuderi, Dyfed Wyn Huws, Annalisa Trama , the RARECARENet WG 1
    Cancer Epidemiology https://doi.org/10.1016/j.canep.2020.101877

  42. Sociodemographic inequalities in patients’ experiences of primary care: an analysis of the General Practice Patient Survey in England between 2011 and 2017

    Catherine L Saunders, Sarah Flynn, Efthalia Massou, Georgios Lyratzopoulos, Gary Abel, Jenni Burt
    Journal of Health Services Research & Policy http://dx.doi.org/10.1177/1355819620986814

  43. Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England

    Kenrick Ng, Peter Wilson, Katherine Mutsvangwa, Luke Hounsome , Jonathan Shamash
    Prostate Cancer and Prostatic diseases https://doi.org/10.1038/s41391-020-00316-x
Subscribe to Publications in 2021